Australian Clinical Labs
Australian Clinical Labs is a leading provider of pathology services in Australia, offering a comprehensive range of diagnostic testing services. The company operates over 50 NATA-accredited laboratories and more than 1,200 collection centers, serving a diverse clientele. Its commitment to quality and innovation positions it as a key player in the healthcare sector.
Short position
Australian Clinical Labs (ASX:ACL) has 4.39% of its shares on issue reported as short positions as of 5 Oct 2026, or about 8,197,284 shares. Over the past 30 days that figure has fallen 0.43 percentage points, and over 90 days it has fallen 3.17 percentage points. Its highest recorded short interest was 11.19% in July 2024. ACL is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Australian Clinical Labs (ACL) company profile
Profile, insiders and operations
Company
AI-generated research profile of Australian Clinical Labs
ACL intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links